Trigger Finger Treatment Guide: Splinting, Steroid Injections and A1 Pulley Release
A clinician-reviewed guide to trigger finger (stenosing tenosynovitis): why the flexor tendon catches at the A1 pulley, how splinting and corticosteroid injections compare, when open or percutaneous release is considered, and what recovery realistically looks like.
Analyzed Article
This fact-check analysis pertains to a specific external article.
Title: Trigger Finger ( Read original article )
Source: StatPearls contributors
Claim-by-Claim Ledger
| ID | Claim | Risk | Verdict | Evidence | Notes |
|---|---|---|---|---|---|
| C1 | Trigger finger is caused by a size mismatch between the flexor tendon and the A1 pulley at the base of the finger, not by a joint problem. | low | supported | S1, V1 | StatPearls describes narrowing of the flexor pulley sheath with hypertrophy and inflammation at the tendon-sheath interface, most often at the A1 pulley, which bears the greatest force. |
| C2 | Incidence is bimodal, peaking before age 8 in children and between ages 40 and 50 in adults, with adult cases more common in women and in the dominant hand. | low | supported | S1 | Directly stated in the StatPearls epidemiology section. |
| C3 | A randomized comparison found no significant difference in pain or function at one year between steroid injection alone, splinting alone, and both combined. | medium | supported | S1 | StatPearls cites this randomized study and concludes splinting alone is reasonable as an initial treatment; it is a single trial, so individual response still varies. |
| C4 | Percutaneous A1 pulley release has an overall reported success rate of about 87%, lower for the index, middle and ring fingers. | medium | partial | S1 | From a retrospective study cited by StatPearls; open release remains the gold standard, and many surgeons avoid percutaneous release in the thumb because the digital nerve crosses the A1 pulley. |
| C5 | Serious complications after open A1 pulley release, such as neurovascular injury, bowstringing or infection requiring reoperation, occur in less than 1% to 4% of cases. | medium | supported | S1 | StatPearls reports most complications are minor (scar tenderness, recurrence, mild extension lag) with significant complications at an incidence of under 1% to 4%. |
Trigger finger treatment begins with activity modification and a splint that blocks the knuckle joint, adds a corticosteroid injection into the tendon sheath if catching persists, and moves to surgical release of the A1 pulley when those fail. The problem is mechanical: a thickened flexor tendon no longer glides through a narrowed pulley at the base of the finger, so the digit catches or locks [S1][V1].
Key numbers
- Most affected sites: the ring finger and thumb, at the A1 pulley over the knuckle [S1]
- Age peaks: before 8 years in children and 40 to 50 years in adults [S1]
- Splinting protocol: metacarpophalangeal blocking splint at 10 to 15 degrees of flexion for 6 to 10 weeks [S1]
- Randomized comparison: no significant difference at 1 year between injection alone, splinting alone, or both [S1]
- Percutaneous A1 pulley release: about 87% overall success in a retrospective series [S1]
- Serious complications after open release: under 1% to 4% [S1]
- Recurrence risk after open release rises with more than 3 pre-operative steroid injections and manual labour [S1]
What trigger finger actually is
Trigger finger is also called stenosing tenosynovitis. Repetitive use or compression causes inflammation of the flexor tendon-sheath complex, the pulley thickens, and a nodule can form on the tendon. Because the flexor apparatus is stronger than the extensor apparatus, bending the finger usually still works; the catch shows up when you try to straighten it, which is why patients describe a finger that locks bent and then snaps open [S1].
The A1 pulley at the metacarpophalangeal joint is the classic site because it bears the greatest force, but triggering can also occur at the A2 or A3 pulleys further down the finger [S1]. Histology shows fibro-cartilaginous metaplasia at the tendon-pulley interface with hypertrophy and inflammation, which is why it behaves like a degenerative overuse tendon problem rather than an infection [S1][S2].
Several medical conditions raise the risk: diabetes, rheumatoid arthritis, gout, thyroid disease, amyloidosis, and carpal tunnel syndrome. If you have hand symptoms on both sides or numbness as well as catching, the nerve should be assessed too — see our carpal tunnel syndrome treatment guide [S1].
How trigger finger is diagnosed
Diagnosis is clinical. A clinician presumes trigger finger when the finger clicks painfully, catches on extension, and a tender inflamed nodule can be felt at the base of the digit in the palm [S1].
Ultrasound is the preferred imaging test if imaging is used at all. It allows dynamic assessment — you can watch the catching happen — and shows pulley thickening and tendon irregularity, though it does not reliably predict the exact site. Plain X-rays are only used to rule out other causes such as an occult fracture; MRI and CT are usually unnecessary [S1].
The differential includes ganglion cysts of the tendon sheath, loose bodies or osteophytes at the knuckle, palmar plate injury, extensor tendon subluxation, and infection inside the tendon sheath [S1]. Thumb-side wrist pain with no locking is more likely de Quervain’s tenosynovitis, a related stenosing tenosynovitis in a different compartment [S4].
Treatment options compared
| Option | What it involves | Typical response | Main limitation |
|---|---|---|---|
| Activity modification | Reduce repetitive gripping and sustained pinch | Gradual, over weeks | Hard with manual work [V3] |
| MCP blocking splint | Knuckle held at 10-15 degrees for 6-10 weeks | Effective for many mild-moderate cases [S1] | Less effective with severe or long-standing symptoms |
| Corticosteroid injection | Steroid into the flexor tendon sheath, blind or ultrasound-guided | Frequently effective; ultrasound guidance gave better early outcomes and faster return to work [S1] | Recurrence; poorer response in diabetes |
| Percutaneous A1 release | Needle release using surface landmarks | About 87% success overall [S1] | Higher failure in index/middle/ring; avoided in thumb by many surgeons |
| Open A1 pulley release | Small open incision dividing the pulley | Gold standard, high success rate [S1] | Serious complications under 1%-4% |
Splinting first is a defensible choice
A randomized study compared steroid injection alone, splinting alone, and both together, and found no significant difference in pain relief or function at one year. On that basis StatPearls suggests splinting alone is reasonable as the initial treatment, particularly for someone who wants to avoid an injection [S1]. The usual prescription is a metacarpophalangeal blocking splint at 10 to 15 degrees of flexion worn for 6 to 10 weeks.
Steroid injection: cheap, quick, not permanent
Injecting corticosteroid into the tendon sheath is inexpensive, easy to perform and less invasive than surgery. It is often the fastest route to relief, but symptoms recur in some patients and full recovery can still take several months. Ultrasound guidance outperformed blind injection in a prospective randomized comparison, producing superior outcomes and a faster return to work early on [S1]. Side effects include tissue atrophy, skin discolouration or hypopigmentation, and infection. Avoid strenuous hand use for a few weeks afterwards to limit the small risk of tendon rupture [S1]. The same risk-benefit logic applies to steroid injections elsewhere, discussed in our joint injection versus surgery decision guide.
Surgery when conservative care fails
Open release of the A1 pulley is the surgical gold standard and is recommended when injections do not resolve the condition. It is particularly favoured in patients with diabetes or rheumatoid arthritis, and in fixed flexion deformities where pulley release alone may not restore function [S1]. A 12-year retrospective study found that having more than three steroid injections before surgery, and doing manual labour, increased recurrence risk after open release — an argument against stacking injections indefinitely [S1]. Most post-operative problems are minor: scar tenderness, pain, recurrent triggering, mild extension lag.
Red flags: when to seek care urgently
Get medical assessment promptly if you have:
- A finger held flexed with severe pain on passive extension, fusiform swelling, and tenderness along the tendon sheath — this is pyogenic flexor tenosynovitis, a surgical emergency [S3]
- Fever, spreading redness or a hot swollen hand [S2]
- A finger locked in a bent position that you cannot straighten with the other hand
- New numbness, tingling or weakness in the hand rather than pure catching [V2]
- Hand pain after a fall or crush injury, where fracture needs excluding
Living with it and preventing recurrence
Recurrence is driven by returning to the same repetitive load, so grip-heavy tools, prolonged pinch grips and vibrating equipment are worth adapting. Warm-up, micro-breaks, padded handles and gradual strengthening once the catching settles all help [V3]. Treating an underlying condition — especially diabetes control or inflammatory arthritis — improves the odds, and some cases resolve as that condition is managed [S1]. Broader overuse tendon strategies are covered in our tendonitis treatment guide.
Frequently asked questions
What causes trigger finger?
Trigger finger, or stenosing tenosynovitis, develops when the flexor tendon of a finger no longer glides smoothly through the A1 pulley at the base of the digit. Repetitive gripping causes microtrauma, thickening and nodule formation, so the tendon catches. It is more common in people with diabetes, rheumatoid arthritis, gout, thyroid disease, amyloidosis and carpal tunnel syndrome.
Does trigger finger go away on its own?
Some mild cases settle, particularly when an underlying condition such as inflammatory arthritis is treated. Most persistent cases need treatment. Splinting the metacarpophalangeal joint in 10 to 15 degrees of flexion for 6 to 10 weeks helps many people, though it works less well when symptoms are severe or long-standing.
How effective is a steroid injection for trigger finger?
Corticosteroid injection into the tendon sheath is a common, low-cost first-line treatment and many patients improve, but symptoms can recur and full recovery may take several months. A randomized study found no significant one-year difference between injection alone, splinting alone and the two combined. People with diabetes tend to respond less well and more often need surgery.
When is surgery needed for trigger finger?
Surgery is considered when splinting and one or more steroid injections fail to relieve locking and pain. Open release of the A1 pulley is the gold standard and has a high success rate. Percutaneous release is an alternative with roughly 87% reported success, but many surgeons avoid it in the thumb because the digital nerve crosses the pulley.
How long does recovery from trigger finger release take?
Most people move the finger immediately after an open A1 pulley release and return to light activity within days to a couple of weeks, with scar tenderness and swelling fading over the following weeks. Full comfort can take longer. After a steroid injection, avoid strenuous hand use for a few weeks to reduce the small risk of tendon rupture.
References
- [S1] StatPearls contributors. Trigger Finger. StatPearls, NCBI Bookshelf. 2024. Source . Accessed 2026-08-27.
- [S2] StatPearls contributors. Tenosynovitis. StatPearls, NCBI Bookshelf. 2023. Source . Accessed 2026-08-27.
- [S3] StatPearls contributors. Pyogenic Flexor Tenosynovitis. StatPearls, NCBI Bookshelf. 2023. Source . Accessed 2026-08-27.
- [S4] StatPearls contributors. De Quervain Tenosynovitis. StatPearls, NCBI Bookshelf. 2024. Source . Accessed 2026-08-27.
- [V1] U.S. National Library of Medicine. Finger Injuries and Disorders. MedlinePlus. 2025. Source . Accessed 2026-08-27.
- [V2] U.S. National Library of Medicine. Hand Injuries and Disorders. MedlinePlus. 2025. Source . Accessed 2026-08-27.
- [V3] U.S. National Library of Medicine. Tendinitis. MedlinePlus. 2025. Source . Accessed 2026-08-27.
Editorial Notes
Educational review only. This content is not personalized medical advice, diagnosis, or treatment. Consult a licensed clinician about your own care.
Explore More In This Topic
Looking for additional coverage in this category? Browse all Tendon and soft tissue pain fact checks.